Attached files
| file | filename |
|---|---|
| EX-4.1 - EXHIBIT 4.1 - Emmaus Life Sciences, Inc. | v328138_ex4-1.htm |
| EX-10.1 - EXHIBIT 10.1 - Emmaus Life Sciences, Inc. | v328138_ex10-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Amendment No. 1 to
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): November 5, 2012
CNS RESPONSE, INC.
(Exact name of Company as specified in its charter)
| Delaware | 0-26285 | 87-0419387 | ||
| (State or other jurisdiction | (Commission File No.) | (I.R.S. Employer | ||
| of incorporation) | Identification No.) |
85 Enterprise, Suite 410
Aliso Viejo, CA 92656
(Address of principal executive offices)
(714) 545-3288
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
EXPLANATORY NOTE
The sole purpose of this amendment to the Current Report on Form 8-K, originally filed by CNS Response, Inc. (the “Registrant”) with the Securities and Exchange Commission on November 9, 2012 (the “Original Form 8-K”), is to file the exhibits referred to in Item 9.01.
No other changes have been made to the Original Form 8-K and the Original Form 8-K has not been modified or updated to reflect events occurring subsequent to its original filing date.
| Item 9.01 | Financial Statements and Exhibits. |
| Exhibit 4.1 | Form of October 2012 Bridge Note. |
| Exhibit 10.1 | Form of Bridge Financing Purchase Agreement. |
SIGNATURES
Pursuant to the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| CNS Response, Inc. | |||
| By: | /s/ Paul Buck | ||
| November 13, 2012 | Paul Buck | ||
| Chief Financial Officer | |||